Navigation Links
Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
Date:1/27/2009

irus, thereby preventing life-threatening diseases from being passed along to transfusion recipients.

"Together these two companies have discovered and developed innovative solutions for the screening and prevention of infectious diseases to help protect the nation's blood supply," said William F. Moore, senior vice president, biomedical services operations, American Red Cross. "We are pleased to see this successful collaboration continue to focus on innovations and reinvestment in technology that will help keep the blood supply as safe as possible."

Unlike standard serological testing, nucleic acid testing (NAT) detects viral RNA and DNA during earlier stages of infection, shortening the window period from infection to detection. Scientific models estimate that NAT reduces the infectious window period of HIV-1, HCV and HBV from 35% to 91%, compared with standard serological methods.

About the Revised Agreement

The collaboration between Gen-Probe and Novartis was established in 1998, and was scheduled to expire in 2013. Under the original terms of the agreement, the companies shared revenue from the sale of blood screening assays. Gen-Probe was responsible for manufacturing costs, while Novartis was responsible for commercial expenses. The companies shared research and development (R&D) costs.

Under the revised agreement, Gen-Probe will continue to be primarily responsible for R&D and manufacturing. Novartis will remain responsible for sales and marketing of the products, but will collaborate more closely with Gen-Probe on sales, marketing and distribution strategies. In addition to sharing R&D costs, the companies will share manufacturing expenses. Gen-Probe also will receive a percentage of end-user revenue that escalates gradually from 2009 until 2015, and remains constant thereafter.

As part of the expanded agreement, Novartis has agreed
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
2. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
3. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
4. Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
5. Gen-Probe Announces Webcasts of Three Upcoming Investor Events
6. Gen-Probe to Webcast Two Upcoming Investor Presentations
7. Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
8. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
9. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
10. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
11. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... September 01, 2014 More than 200 ... to a federal litigation that continues to progress in ... Liebhard LLP reports. , A federal Case List ... over the widely-used cholesterol medication by plaintiffs who developed ... to claims, Pfizer Inc. failed to adequately warn patients ...
(Date:9/1/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 (HealthDay ... American aid workers successfully cured a group of monkeys infected ... The drug, ZMapp, prompted recovery in all 18 monkeys who ... five days after infection. ZMapp even cured monkeys with ... away from death, said study senior author Gary Kobinger, chief ...
(Date:9/1/2014)... September 01, 2014 As well as ... Derek is currently pursuing counselor certification in Louisiana. ... through the CPI training program as well as the ... have grown both personally and professionally. I am ... am competently able to do so. As a ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Bioinformatics ... organize and analyze biological and genetic data. A ... activity of developing software tools to generate and ... be confused with biological computation. While bioinformatics simply ... of biology can its related concepts, biological computation ...
(Date:9/1/2014)... NJ (PRWEB) September 01, 2014 Registration is ... The Warriors® 5K and 1-Mile Race to be held on ... The Plaza Court Yard at Harmon Meadow in Secaucus, New ... The Warriors®, a national nonprofit dedicated to restoring a sense ... our service members and our military families. , General registration ...
Breaking Medicine News(10 mins):Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 2Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2
... PHOENIX, July 1 The boards of ... Long Term Care announced today the appointment ... operations, effective,immediately. In Arizona, SCAN offers a ... also provides long-term care services to,individuals enrolled ...
... & Ellis Healthcare,REIT, Inc. today announced the acquisition ... properties comprising 20 buildings,located throughout Indianapolis., Medical ... of,gross leaseable area. The portfolio is 91 percent ... which has occupancy in nine of the 13,properties ...
... processing in brain, affect development, researcher says , , TUESDAY, ... intensive care must undergo numerous painful interventions, not enough ... suggests. , Of the 42,413 painful procedures included in ... medications, and just 18.2 percent received non-pharmacological pain therapy. ...
... by University of Michigan scientists suggest that people who experience ... different forms of the disease that require different kinds of ... point to a time when doctors will be able to ... help MS patients, using available drugs and new ones in ...
... for better treatments of certain malignancies , , TUESDAY, July 1 ... a kind of dimmer switch to stop a "cancer signal" ... don,t represent a cure, and no one knows if they ... research does clear a pathway for scientists to follow as ...
... Insurance Services,Inc., has been sold to Assurance Investment Partners ... Shield in Kentucky, Arison has six,offices across Kentucky and ... individuals., The company will continue to operate under ... employees will be employed by AIP. Paul,Anderson, who served ...
Cached Medicine News:Health News:SCAN Health Plan Arizona and SCAN Long Term Care Appoints Thomas Lescault President of Arizona Operations 2Health News:Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 3 in Indianapolis 2Health News:Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 3 in Indianapolis 3Health News:Newborns in Intensive Care Often Exposed to Pain 2Health News:Newborns in Intensive Care Often Exposed to Pain 3Health News:Best treatment for MS may depend on disease subtype 2Health News:Best treatment for MS may depend on disease subtype 3Health News:Scientists Find Way to Dim Cancer Switch 2Health News:Assurance Investment Partners Purchases Arison Insurance Services from Anthem Blue Cross and Blue Shield 2
(Date:8/29/2014)... 29, 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the ... turnkey support services for the lawfully organized cannabis ... and approved the Company,s name and symbol change ... will be known as Chuma Holdings, Inc. ... a merger with the Company,s wholly-owned subsidiary, Chuma ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- SAM Medical Products ... for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that it has ... address a potential issue with a clip used ... Axilla application of the SAM Junctional Tourniquet (SJT).  ...
(Date:8/29/2014)... 29, 2014   Mast Therapeutics, Inc. ... today that Santosh Vetticaden, Chief Medical Officer and ... for personal reasons, in mid-September.  Edwin L. ... Aires Pharmaceuticals, which Mast acquired earlier this year, ... Company,s interim Chief Medical Officer.  Dr. Parsley previously ...
Breaking Medicine Technology:CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... 2011 Boston Scientific Corporation (NYSE: BSX ... the First Circuit has affirmed the dismissal of a ... Company,s TAXUS® Express2 Paclitaxel-Eluting Coronary Stent System in 2004. ... Public Employees, Retirement System, had previously been dismissed by ...
... 2011 CareFusion Corp. (NYSE: CFN ), a ... quarter and fiscal year ended June 30, 2011. ... margin expansion and the benefit of strong spending controls drove ... quarter and for the year," said Kieran Gallahue, chairman and ...
Cached Medicine Technology:Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case 2Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case 3CareFusion Reports Fourth Quarter and Fiscal 2011 Results 2CareFusion Reports Fourth Quarter and Fiscal 2011 Results 3CareFusion Reports Fourth Quarter and Fiscal 2011 Results 4CareFusion Reports Fourth Quarter and Fiscal 2011 Results 5CareFusion Reports Fourth Quarter and Fiscal 2011 Results 6CareFusion Reports Fourth Quarter and Fiscal 2011 Results 7CareFusion Reports Fourth Quarter and Fiscal 2011 Results 8CareFusion Reports Fourth Quarter and Fiscal 2011 Results 9CareFusion Reports Fourth Quarter and Fiscal 2011 Results 10CareFusion Reports Fourth Quarter and Fiscal 2011 Results 11CareFusion Reports Fourth Quarter and Fiscal 2011 Results 12CareFusion Reports Fourth Quarter and Fiscal 2011 Results 13CareFusion Reports Fourth Quarter and Fiscal 2011 Results 14CareFusion Reports Fourth Quarter and Fiscal 2011 Results 15
... are built to deliver maximum ... The systems have the capacity ... in todays environment. Plus, ... and maximize user-friendliness, the UniCel ...
... is a unique double loaded anchor perfect for ... Poly-L Lactic Acid (PLLA) and comes in two ... the suture ends for open repairs, and can ... tip inserter allows insertion with minimal procedural steps ...
... The E-Z Tac™ implantThe USS Sports Medicine™ E-Z ... to attach soft tissue to bone. The resorbable ... in the bone and is used to reattach ... made of a resorbable copolymer, a polyester derivative ...
Umbrella Cancellous Harpoon...
Medicine Products: